STOCK TITAN

Cyrusone SEC Filings

CONE NASDAQ

Welcome to our dedicated page for Cyrusone SEC filings (Ticker: CONE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Cyrusone's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Cyrusone's regulatory disclosures and financial reporting.

Rhea-AI Summary

Green Dot Corporation supplements disclosures for its proposed merger with CommerceOne and the related separation and sale of Green Dot’s non‑bank fintech assets to OpCo. The companies disclosed supplemental financial analyses, indicated implied valuation ranges (e.g., Combined company equity reference range of $590 million to $755 million), and announced special stockholder meetings for June 23, 2026. The filing notes three shareholder lawsuits alleging disclosure deficiencies and states the parties are providing supplemental disclosures while denying liability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
merger

FAQ

How many Cyrusone (CONE) SEC filings are available on StockTitan?

StockTitan tracks 1 SEC filings for Cyrusone (CONE), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Cyrusone (CONE)?

The most recent SEC filing for Cyrusone (CONE) was filed on June 16, 2026.